Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Basso, Daniela ^a   Fogar, Paola ^a   Falconi, Massimo ^b,c   Fadi, Elisa ^a   Sperti, Cosimo ^a   Frasson, Chiara ^a   Greco, Eliana ^a   Tamburrino, Domenico ^b   Teolato, Sara ^a   Moz, Stefania ^a   Bozzato, Dania ^a   Pelloso, Michela ^a   Padoan, Andrea ^a   de Franchis, Giuseppe ^a   Gnatta, Elisa ^a   Facco, Monica ^a   Zambon, Carlo Federico ^a   Navaglia, Filippo ^a   Pasquali, Claudio ^a   Basso, Giuseppe ^a   Semenzato, Gianpietro ^a   Pedrazzoli, Sergio ^a   Pederzoli, Paolo ^b   Plebani, Mario ^a   more..

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CD33 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; MESSENGER RNA; PROGRAMMED DEATH 1 LIGAND 1;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BONE MARROW CELL; CALGRANULIN A GENE; CALGRANULIN B GENE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMATURE MYELOID CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PANCREAS ADENOCARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD274; BASE SEQUENCE; CELL SEPARATION; CTLA-4 ANTIGEN; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SPLEEN; YOUNG ADULT;

EID: 84872874594     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054824     Document Type: Article

References (63)

1. Klöppel G, Perren A, Heitz PU, (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014: 13-27.
2. Hidalgo M, (2010) Pancreatic cancer. N Engl J Med 362: 1605-1617.
3. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
4. Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, et al. (2008) The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10: 1349-1355.
5. Basso D, Greco E, Padoan A, Fogar P, Scorzeto M, et al. (2011) Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8). J Cell Physiol 226: 456-468.
6. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
7. Ryschich E, Nötzel T, Hinz U, Autschbach F, Ferguson J, et al. (2005) Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma. Clin Cancer Res 11: 498-504.
8. Lu T, Ramakrishnan R, Altiok S, Youn JI, Cheng P, et al. (2011) Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J Clin Invest 121: 4015-4029.
9. Fukunaga A, Miyamoto M, Cho Y, Murakami S, Kawarada Y, et al. (2004) CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 28: e26-e31.
10. Bellone G, Carbone A, Smirne C, Scirelli T, Buffolino A, et al. (2006) Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J Immunol 177: 3448-3460.
11. Takahashi K, Toyokawa H, Takai S, Satoi S, Yanagimoto H, et al. (2006) Surgical influence of pancreatectomy on the function and count of circulating dendritic cells in patients with pancreatic cancer. Cancer Immunol Immunother 55: 775-784.
12. Bharadwaj U, Li M, Zhang R, Chen C, Yao Q, (2007) Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res 67: 5479-5488.
13. Nishikawa H, Sakaguchi S, (2010) Regulatory T cells in tumor immunity. Int J Cancer 127: 759-767.
14. Hiraoka N, Onozato K, Kosuge T, Hirohashi S, (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12: 5423-5434.
15. Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Grüssel S, et al. (2007) Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 67: 8344-8350.
16. Kerkar SP, Restifo NP, (2012) Cellular constituents of immune escape within the tumor microenvironment. Cancer Res 72: 3125-3130.
17. Kusmartsev S, Gabrilovich DI, (2006) Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother 55: 237-245.
18. Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, et al. (2008) Myeloid-derived suppressor cell role in tumor-related inflammation. Cancer Lett 267: 216-225.
19. Ostrand-Rosenberg S, Sinha P, (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182: 4499-4506.
20. Youn JI, Gabrilovich DI, (2010) The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 40: 2969-2975.
21. Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, et al. (2007) Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 67: 9518-9527.
22. Connolly MK, Mallen-St Clair J, Bedrosian AS, Malhotra A, Vera V, et al. (2010) Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. J Leukoc Biol 87: 713-725.
23. Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, et al. (2010) HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 207: 2439-2453.
24. Tseng WW, Winer D, Kenkel JA, Choi O, Shain AH, et al. (2010) Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Clin Cancer Res 16: 3684-3695.
25. Pilon-Thomas S, Nelson N, Vohra N, Jerald M, Pendleton L, et al. (2011) Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function. PLoS One 6: e27729.
26. Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, et al. (2012) Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21: 822-835.
27. Zhao F, Obermann S, von Wasielewski R, Haile L, Manns MP, et al. (2009) Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma. Immunology 128: 141-149.
28. Ishizaki H, Manuel ER, Song GY, Srivastava T, Sun S, et al. (2011) Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model. Cancer Immunol Immunother 60: 99-109.
29. Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, et al. (2010) Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32: 790-802.
30. Nagaraj S, Youn JI, Weber H, Iclozan C, Lu L, et al. (2010) Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clin Cancer Res 16: 1812-1823.
31. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW, (2011) Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 60: 1419-1430.
32. Porembka MR, Mitchem JB, Belt BA, Hsieh CS, Lee HM, et al. (2012) Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. Cancer Immunol Immunother 61: 1373-1385.
33. Almand B, Clark JI, Nikitina E, van Beynen J, English NR, et al. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 166: 678-689.
34. Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, et al. (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 69: 1553-1560.
35. Tjomsland V, Spångeus A, Sandström P, Borch K, Messmer D, et al. (2010) Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor. PLoS One 5: e13441.
36. Kusmartsev S, Eruslanov E, Kübler H, Tseng T, Sakai Y, et al. (2008) Oxidative stress regulates expression of VEGFR1 in myeloid cells: link to tumor-induced immune suppression in renal cell carcinoma. J Immunol 181: 346-353.
37. Nomi T, Sho M, Akahori T, Hamada K, Kubo A, et al. (2007) Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clin Cancer Res 13: 2151-2157.
38. Loos M, Giese NA, Kleeff J, Giese T, Gaida MM, et al. (2008) Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer. Cancer Lett 268: 98-109.
39. Shevach EM, (2008) Immunology. Regulating suppression. Science 322: 202-203.
40. Rosenblatt J, Glotzbecker B, Mills H, Vasir B, Tzachanis D, et al. (2011) PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine. J Immunother 34: 409-418.
41. Durgan K, Ali M, Warner P, Latchman YE, (2011) Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model. Cancer Immunol Immunother 60: 547-558.
42. Yang J, Riella LV, Chock S, Liu T, Zhao X, et al. (2011) The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. J Immunol 187: 1113-1119.
43. Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, et al. (2011) Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332: 600-603.
44. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, et al. (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363: 711-723.
45. Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, et al. (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366: 2455-2465.
46. Sheikh AA, Vimalachandran D, Thompson CC, Jenkins RE, Nedjadi T, et al. (2007) The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells. Proteomics 7: 1929-1940.
47. Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, et al. (2008) Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181: 4666-4675.
48. Clark CE, Beatty GL, Vonderheide RH, (2009) Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer. Cancer Lett 279: 1-7.
49. Autissier P, Soulas C, Burdo TH, Williams KC, (2010) Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry 77: 410-419.
50. Palucka K, Ueno H, Fay J, Banchereau J, (2011) Dendritic cells and immunity against cancer. J Intern Med 269: 64-73.
51. Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Krüger C, et al. (2008) A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135: 234-243.
52. Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, et al. (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 58: 49-59.
53. Poschke I, Mougiakakos D, Hansson J, Masucci GV, Kiessling R, (2010) Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res 70: 4335-4345.
54. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, et al. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174: 561-569.
55. Wang XB, Fan ZZ, Anton D, Vollenhoven AV, Ni ZH, et al. (2011) CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation. BMC Immunol 12: 21.
56. Zou W, Chen L, (2008) Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 8: 467-477.
57. Fogar P, Basso D, Fadi E, Greco E, Pantano G, et al. (2011) Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle. Pancreas 40: 1131-1137.
58. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, et al. (2008) Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 205: 2235-2249.
59. Kim MS, Kuppireddy SV, Sakamuri S, Singal M, Getnet D, et al. (2012) Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). J Proteome Res 11: 5556-5563.
60. Makawita S, Smith C, Batruch I, Zheng Y, Rückert F, et al. (2011) Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol Cell Proteomics 10: M111.008599.
61. Zhang Y, Li M, Wang H, Fisher WE, Lin PH, et al. (2009) Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg 33: 698-709.
62. Segerer SE, Rieger L, Kapp M, Dombrowski Y, Müller N, et al. (2012) MIC-1 (a multifunctional modulator of dendritic cell phenotype and function) is produced by decidual stromal cells and trophoblasts. Hum Reprod 27: 200-209.
63. Almog N, Ma L, Schwager C, Brinkmann BG, Beheshti A, et al. (2012) Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype. PLoS One 7: e44001.